
How PreFree works
PreFree uses a multimodal, CE-marked prediction model that combines clinical patient data with the biomarkers sFlt-1 and PlGF to identify serious risks associated with preeclampsia at an early stage. The software provides an individualized risk prediction for the next two weeks and supports healthcare professionals in making informed decisions about further monitoring, potential hospital admission, or safe discharge. Additionally, a digital patient diary enables the structured collection of relevant health data from home.
The application is used in three simple steps:
Who is PreFree designed for?
The application is intended for physicians specializing in obstetrics and prenatal medicine, as well as midwives and nurses. Midwives and nurses can enter the data without having to interpret the results medically.
The patient group includes pregnant women aged 18 to 45 with a singleton pregnancy between 20+0 and 40+6 weeks of gestation (WG) who are at increased risk for preeclampsia.
The accompanying PatApp is available for patients.
Important: PreFree is not a standalone diagnostic tool. For exclusion criteria (including severe preeclampsia, HELLP syndrome, eclampsia, and multiple pregnancies), see the instructions for use.
Instructions for use
Please use the user manual that corresponds to your software version. You can find the version in the software’s “Info” menu.
| Software Version | Language | Document | Date of Issue |
|---|---|---|---|
| V1.2.2 (current) | German | Click here | December 3, 2025 |
| V1.2.2 (current) | English | Click here | December 8, 2025 |
Upon request, you will receive a free printed copy of the user manual within 7 calendar days. Please send your request to [email protected] or call +49 6151 8618 0.
A PDF reader is required to open the documents.
Regulatory information
Manufacturer: BAYOOCARE GmbH, Europaplatz 5, 64293 Darmstadt, Germany
Classification: Class IIa medical device according to Regulation (EU) 2017/745 · CE 0123
Basic UDI-DI: 42519815PreFreeWebED
Development & Operation: NeoPredics AG, Regensburg, Germany
Additional Links
- Privacy Policy (NeoPredics AG)
- Terms of Use
- Incidents & Feedback: Please report any problems, malfunctions, or incidents using the form in the Help section of the software or app, or by emailing [email protected].
